328 related articles for article (PubMed ID: 9356498)
21. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.
Kwun HJ; da Silva SR; Shah IM; Blake N; Moore PS; Chang Y
J Virol; 2007 Aug; 81(15):8225-35. PubMed ID: 17522213
[TBL] [Abstract][Full Text] [Related]
23. The Gly-Ala repeat modulates the interaction of Epstein-Barr virus nuclear antigen-1 with cellular chromatin.
Coppotelli G; Mughal N; Masucci MG
Biochem Biophys Res Commun; 2013 Feb; 431(4):706-11. PubMed ID: 23348225
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of ubiquitin/proteasome-dependent proteolysis in Saccharomyces cerevisiae by a Gly-Ala repeat.
Heessen S; Dantuma NP; Tessarz P; Jellne M; Masucci MG
FEBS Lett; 2003 Dec; 555(2):397-404. PubMed ID: 14644450
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.
Mautner J; Pich D; Nimmerjahn F; Milosevic S; Adhikary D; Christoph H; Witter K; Bornkamm GW; Hammerschmidt W; Behrends U
Eur J Immunol; 2004 Sep; 34(9):2500-9. PubMed ID: 15307182
[TBL] [Abstract][Full Text] [Related]
26. Immunology. Hide and seek in the peptidome.
Yewdell JW
Science; 2003 Sep; 301(5638):1334-5. PubMed ID: 12958347
[No Abstract] [Full Text] [Related]
27. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.
Lautscham G; Rickinson A; Blake N
Microbes Infect; 2003 Apr; 5(4):291-9. PubMed ID: 12706442
[TBL] [Abstract][Full Text] [Related]
28. Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.
Heessen S; Leonchiks A; Issaeva N; Sharipo A; Selivanova G; Masucci MG; Dantuma NP
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1532-7. PubMed ID: 11805282
[TBL] [Abstract][Full Text] [Related]
29. A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.
Voisset C; Daskalogianni C; Contesse MA; Mazars A; Arbach H; Le Cann M; Soubigou F; Apcher S; Fåhraeus R; Blondel M
Dis Model Mech; 2014 Apr; 7(4):435-44. PubMed ID: 24558096
[TBL] [Abstract][Full Text] [Related]
30. EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells.
Kashuba E; Mattsson K; Pokrovskaja K; Kiss C; Protopopova M; Ehlin-Henriksson B; Klein G; Szekely L
Int J Cancer; 2003 Jul; 105(5):644-53. PubMed ID: 12740913
[TBL] [Abstract][Full Text] [Related]
31. Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.
Tellam JT; Lekieffre L; Zhong J; Lynn DJ; Khanna R
PLoS Pathog; 2012 Dec; 8(12):e1003112. PubMed ID: 23300450
[TBL] [Abstract][Full Text] [Related]
32. The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.
Wang H; Bu L; Wang C; Zhang Y; Zhou H; Zhang X; Guo W; Long C; Guo D; Sun X
Cell Death Dis; 2018 Jun; 9(7):734. PubMed ID: 29959331
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence.
Leonchiks A; Stavropoulou V; Sharipo A; Masucci MG
FEBS Lett; 2002 Jul; 522(1-3):93-8. PubMed ID: 12095625
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing.
Jones RJ; Smith LJ; Dawson CW; Haigh T; Blake NW; Young LS
Virology; 2003 Sep; 313(2):663-76. PubMed ID: 12954232
[TBL] [Abstract][Full Text] [Related]
35. The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines.
Ong KW; Wilson AD; Hirst TR; Morgan AJ
J Virol; 2003 Apr; 77(7):4298-305. PubMed ID: 12634387
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.
Voo KS; Fu T; Wang HY; Tellam J; Heslop HE; Brenner MK; Rooney CM; Wang RF
J Exp Med; 2004 Feb; 199(4):459-70. PubMed ID: 14769850
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells.
Touitou R; O'Nions J; Heaney J; Allday MJ
J Gen Virol; 2005 May; 86(Pt 5):1269-1277. PubMed ID: 15831937
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
[TBL] [Abstract][Full Text] [Related]
39. Lessons from an age-old war.
Powis SH
Nat Med; 1998 Aug; 4(8):887-8. PubMed ID: 9701231
[No Abstract] [Full Text] [Related]
40. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
Sharipo A; Imreh M; Leonchiks A; Imreh S; Masucci MG
Nat Med; 1998 Aug; 4(8):939-44. PubMed ID: 9701247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
